Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Novartis India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500672NSE Symbol: NOVARTINDP/E(TTM):24.46
ISIN Demat:INE234A01025Div & Yield %:2.89EPS(TTM):35.4
Book Value(Rs):295.3510972Market Cap ( Cr.):2137.98Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 335.07378.74399.87381.35438.25490.68
Excise Duty0.000.000.000.000.000.00
Net Sales335.07378.74399.87381.35438.25490.68
Other Income 61.6858.1133.1933.0936.1478.26
Stock Adjustments -9.86-2.359.12-10.74-1.833.95
Total Income386.89434.50442.18403.70472.56572.89
EXPENDITURE :      
Raw Materials 189.98199.34187.26135.88180.49202.60
Power & Fuel Cost0.180.350.530.531.271.79
Employee Cost 22.9635.64101.89108.51113.87117.11
Other Manufacturing Expenses 5.0012.5831.1533.5136.1938.75
Selling and Administration Expenses 33.7848.0057.6155.7380.43107.03
Miscellaneous Expenses 8.0515.4053.089.6612.1415.07
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure259.95311.31431.52343.82424.39482.35
Operating Profit126.94123.1910.6659.8848.1790.54
Interest 1.491.754.837.686.391.59
Gross Profit125.45121.445.8352.2041.7888.95
Depreciation2.616.069.6512.1613.143.18
Profit Before Tax122.84115.38-3.8240.0428.6485.77
Tax37.631.68-0.4422.6215.2233.27
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.0210.340.34-3.483.340.73
Reported Net Profit85.19103.36-3.7220.9010.0851.77
Extraordinary Items 1.990.17-44.680.03-0.010.01
Adjusted Net Profit83.20103.1940.9620.8710.0951.76
Adjst. below Net Profit 1.213.118.19-6.09-24.81-3.46
P & L Balance brought forward759.72677.94698.16708.04747.46723.84
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 117.2824.6924.6924.6924.6924.69
P & L Balance carried down728.84759.72677.94698.16708.04747.46
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %500.00950.00200.00200.00200.00200.00
Earnings Per Share-Unit Curr34.5241.88-1.518.474.0820.98
Earnings Per Share(Adj)-Unit Curr34.5241.88-1.518.474.0820.98
Book Value-Unit Curr301.79314.29280.27288.16292.03307.61